Uncategorized
Imprimis reports $2.5 million net loss in third quarter
Imprimis Pharmaceuticals reported a net loss of $2.5 million, or $0.27 per common share, in the third quarter, compared with a loss of $2.1 million, or $0.23 per common share, in the third quarter of last year, according to a press release.Total revenues were $0.4 million in the third quarter, an increase from $2,500 in total revenues the year before.